Groups information

Group name

S-RARPĀ 

BCR
Continence

Continence

56 (93.3%)

remark

Urinary continence

Sexual Function
PSA

PSA

0.031 (0.015)

p-value

1

remark

postoperative total PSA, ng/mL

Complications or other prognosis
Positive surgical margin (PSM)
Other quality of life
Surgical related outcomes
Survival Outcome
Survival Outcome
Other outcomes
Follow Up Time

Follow Up Time

median follow-up periods 20.0 months